Doctors, Drug Trials and Genetics - Clinical Research Informer

Fatty liver disease: With little early detection, more challenging drug development

pharmaphorum

AUGUST 25, 2022

That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. Obesity, diabetes, and genetics are the primary drivers, and COVID is about to make this exponentially worse.

Development

Development Drugs Trials Medicine

Why Black People Remain Underrepresented in Clinical Trials

XTalks

FEBRUARY 25, 2022

Despite these statistics, in the US, Black people only constitute five percent of all clinical trial participants. The overwhelming majority of trial participants nationwide are white. However, the links between race-based genetics and disease are not quite clear. Personalized Medicine.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Clinical Research Informer

Fatty liver disease: With little early detection, more challenging drug development

Why Black People Remain Underrepresented in Clinical Trials

Webinars

Stay Connected